Alterity Therapeutics to Present at the MST Access ‘Hidden Gems in Life Sciences’ Webinar
13 6월 2024 - 8:22AM
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the
Company”), a biotechnology company dedicated to developing disease
modifying treatments for neurodegenerative diseases, today
announced that David Stamler, M.D., Chief Executive Officer will
present a company overview at the MST Access ‘Hidden Gems in Life
Sciences’ webinar on Thursday, 13 June 2024 in Australia /
Wednesday, 12 June 2024 in the United States.
Details are listed below and registration is
required.
Webcast details
AUSTRALIA PARTICIPANTS: |
|
Date: |
Thursday, 13
June 2024 |
|
Time: |
1:30 p.m. AEST (Sydney/Melbourne) |
|
|
|
UNITED STATES PARTICIPANTS: |
|
Date: |
Wednesday, 12 June 2024 |
|
Time: |
8:30 p.m. Pacific Time |
|
|
11:30 p.m. Eastern Time |
To join the presentation,
please click the webinar link
here.
Investors will have the opportunity to ask questions during the
call, at the conclusion of the presentation.
A recording of the webinar will be made available on the
Alterity Therapeutics website after the event, which you can access
here: www.alteritytherapeutics.com.
About Alterity Therapeutics
Limited
Alterity Therapeutics is a clinical stage
biotechnology company dedicated to creating an alternate future for
people living with neurodegenerative diseases. The Company’s
lead asset, ATH434, has the potential to treat various Parkinsonian
disorders and is currently being evaluated in two Phase 2 clinical
trials in Multiple System Atrophy. Alterity also has a broad drug
discovery platform generating patentable chemical compounds to
treat the underlying pathology of neurological diseases. The
Company is based in Melbourne, Australia, and San Francisco,
California, USA. For further information please visit the Company’s
website at www.alteritytherapeutics.com.
Authorisation & Additional
informationThis announcement was authorized by David
Stamler, CEO of Alterity Therapeutics Limited.
Investor and Media Contacts:
AustraliaHannah
Howlettwe-aualteritytherapeutics@we-worldwide.com+61 450 648
064
U.S.Remy Bernardaremy.bernarda@iradvisory.com
+1 (415) 203-6386
Alterity Therapeutics (NASDAQ:ATHE)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Alterity Therapeutics (NASDAQ:ATHE)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024